These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36707189)

  • 21. BODE index and GOLD staging as predictors of 1-year exacerbation risk in chronic obstructive pulmonary disease.
    Faganello MM; Tanni SE; Sanchez FF; Pelegrino NR; Lucheta PA; Godoy I
    Am J Med Sci; 2010 Jan; 339(1):10-4. PubMed ID: 19926966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative computed tomography measurements to evaluate airway disease in chronic obstructive pulmonary disease: Relationship to physiological measurements, clinical index and visual assessment of airway disease.
    Nambu A; Zach J; Schroeder J; Jin G; Kim SS; Kim YI; Schnell C; Bowler R; Lynch DA
    Eur J Radiol; 2016 Nov; 85(11):2144-2151. PubMed ID: 27776670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
    Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
    JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
    Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD).
    Ni H; Moe S; Soe Z; Myint KT; Viswanathan KN
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011594. PubMed ID: 30536566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Respiratory exacerbations are associated with muscle loss in current and former smokers.
    Mason SE; Moreta-Martinez R; Labaki WW; Strand M; Baraghoshi D; Regan EA; Bon J; San Jose Estepar R; Casaburi R; McDonald MN; Rossiter H; Make BJ; Dransfield MT; Han MK; Young KA; Kinney G; Hokanson JE; San Jose Estepar R; Washko GR; ;
    Thorax; 2021 Jun; 76(6):554-560. PubMed ID: 33574123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Phenotypes of Atopy and Asthma in COPD: A Meta-analysis of SPIROMICS and COPDGene.
    Putcha N; Fawzy A; Matsui EC; Liu MC; Bowler RP; Woodruff PG; O'Neal WK; Comellas AP; Han MK; Dransfield MT; Wells JM; Lugogo N; Gao L; Talbot CC; Hoffman EA; Cooper CB; Paulin LM; Kanner RE; Criner G; Ortega VE; Barr RG; Krishnan JA; Martinez FJ; Drummond MB; Wise RA; Diette GB; Hersh CP; Hansel NN
    Chest; 2020 Dec; 158(6):2333-2345. PubMed ID: 32450244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small Airway Disease and Emphysema Are Associated with Future Exacerbations in Smokers with CT-derived Bronchiectasis and COPD: Results from the COPDGene Cohort.
    Maselli DJ; Yen A; Wang W; Okajima Y; Dolliver WR; Mercugliano C; Anzueto A; Restrepo MI; Aksamit TR; Basavaraj A; Aliberti S; Young KA; Kinney GL; Wells JM; San José Estépar R; Lynch DA; Diaz AA
    Radiology; 2021 Sep; 300(3):706-714. PubMed ID: 34156303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of disease severity in COPD: a deep learning approach for anomaly-based quantitative assessment of chest CT.
    Almeida SD; Norajitra T; Lüth CT; Wald T; Weru V; Nolden M; Jäger PF; von Stackelberg O; Heußel CP; Weinheimer O; Biederer J; Kauczor HU; Maier-Hein K
    Eur Radiol; 2024 Jul; 34(7):4379-4392. PubMed ID: 38150075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis.
    Janjua S; Mathioudakis AG; Fortescue R; Walker RA; Sharif S; Threapleton CJ; Dias S
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013198. PubMed ID: 33448349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Dysanapsis With Chronic Obstructive Pulmonary Disease Among Older Adults.
    Smith BM; Kirby M; Hoffman EA; Kronmal RA; Aaron SD; Allen NB; Bertoni A; Coxson HO; Cooper C; Couper DJ; Criner G; Dransfield MT; Han MK; Hansel NN; Jacobs DR; Kaufman JD; Lin CL; Manichaikul A; Martinez FJ; Michos ED; Oelsner EC; Paine R; Watson KE; Benedetti A; Tan WC; Bourbeau J; Woodruff PG; Barr RG;
    JAMA; 2020 Jun; 323(22):2268-2280. PubMed ID: 32515814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ACCEPT 2·0: Recalibrating and externally validating the Acute COPD exacerbation prediction tool (ACCEPT).
    Safari A; Adibi A; Sin DD; Lee TY; Ho JK; Sadatsafavi M
    EClinicalMedicine; 2022 Sep; 51():101574. PubMed ID: 35898315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenotyping COPD exacerbations using imaging and blood-based biomarkers.
    Alotaibi NM; Chen V; Hollander Z; Hague CJ; Murphy DT; Leipsic JA; DeMarco ML; FitzGerald JM; McManus BM; Ng RT; Sin DD
    Int J Chron Obstruct Pulmon Dis; 2018; 13():217-229. PubMed ID: 29386890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of chronic obstructive pulmonary disease in lung cancer screening computed tomographic scans.
    Mets OM; Buckens CF; Zanen P; Isgum I; van Ginneken B; Prokop M; Gietema HA; Lammers JW; Vliegenthart R; Oudkerk M; van Klaveren RJ; de Koning HJ; Mali WP; de Jong PA
    JAMA; 2011 Oct; 306(16):1775-81. PubMed ID: 22028353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discriminative Accuracy of Chronic Obstructive Pulmonary Disease Screening Instruments in 3 Low- and Middle-Income Country Settings.
    Siddharthan T; Pollard SL; Quaderi SA; Rykiel NA; Wosu AC; Alupo P; Barber JA; Cárdenas MK; Chandyo RK; Flores-Flores O; Kirenga B; Miranda JJ; Mohan S; Ricciardi F; Sharma AK; Das SK; Shrestha L; Soares MO; Checkley W; Hurst JR;
    JAMA; 2022 Jan; 327(2):151-160. PubMed ID: 35015039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discriminative Accuracy of the CAPTURE Tool for Identifying Chronic Obstructive Pulmonary Disease in US Primary Care Settings.
    Martinez FJ; Han MK; Lopez C; Murray S; Mannino D; Anderson S; Brown R; Dolor R; Elder N; Joo M; Khan I; Knox LM; Meldrum C; Peters E; Spino C; Tapp H; Thomashow B; Zittleman L; Make B; Yawn BP;
    JAMA; 2023 Feb; 329(6):490-501. PubMed ID: 36786790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Characteristics and Frequency of Chronic Obstructive Pulmonary Disease Exacerbations in Korean Patients: Findings From the KOCOSS Cohort 2012-2021.
    Rhee CK; Choi JY; Park YB; Yoo KH
    J Korean Med Sci; 2024 May; 39(19):e164. PubMed ID: 38769923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiographic lung volumes predict progression to COPD in smokers with preserved spirometry in SPIROMICS.
    Arjomandi M; Zeng S; Barjaktarevic I; Barr RG; Bleecker ER; Bowler RP; Buhr RG; Criner GJ; Comellas AP; Cooper CB; Couper DJ; Curtis JL; Dransfield MT; Han MK; Hansel NN; Hoffman EA; Kaner RJ; Kanner RE; Krishnan JA; Paine R; Peters SP; Rennard SI; Woodruff PG;
    Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31439683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diaphragm Morphology Assessed by Computed Tomography in Chronic Obstructive Pulmonary Disease.
    Donovan AA; Johnston G; Moore M; Jensen D; Benedetti A; Coxson HO; Gottfried SB; Petrof BJ; Bourbeau J; Smith BM
    Ann Am Thorac Soc; 2021 Jun; 18(6):955-962. PubMed ID: 33321048
    [No Abstract]   [Full Text] [Related]  

  • 40. Identification of frequent acute exacerbations phenotype in COPD patients based on imaging and clinical characteristics.
    Zhu D; Dai H; Zhu H; Fang Y; Zhou H; Yang Z; Chu S; Xi Q
    Respir Med; 2023 Apr; 209():107150. PubMed ID: 36758904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.